| IP/C/M/77, IP/C/M/77/Add.1 |
13 CONCERNS WITH RESPECT TO MEASURES RELATED TO PLAIN PACKAGING OF TOBACCO PRODUCTS AND THEIR COMPATIBILITY WITH THE TRIPS AGREEMENT |
World Health Organization (WHO) |
28/10/2014-29/10/2014 |
19/02/2015 |
|
| IP/C/M/78, IP/C/M/78/Add.1 |
12 1 CONCERNS WITH RESPECT TO PROPOSALS FOR PLAIN PACKAGING OF TOBACCO PRODUCTS IN THE UNITED KINGDOM AND Ireland |
World Health Organization (WHO) |
24/02/2015-25/02/2015 |
04/05/2015 |
|
| IP/C/M/79, IP/C/M/79/Add.1 |
11 Request for an Extension of the Transitional Period under Article 66.1 for Least Developed Country Members with respect to Pharmaceutical Products and for Waivers from the Obligation of Articles 70.8 and 70. |
World Health Organization (WHO) |
09/06/2015-10/06/2015 |
02/09/2015 |
|
| IP/C/M/80, IP/C/M/80/Add.1 |
12 TECHNICAL COOPERATION AND CAPACITY-BUILDING |
World Health Organization (WHO) |
15/10/2015-23/11/2015 |
22/02/2016 |
|
| IP/C/M/83, IP/C/M/83/Add.1 |
11 Technical Cooperation and Capacity-Building |
World Health Organization (WHO) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
| IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
World Health Organization (WHO) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
| IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
World Health Organization (WHO) |
01/03/2017-02/03/2017 |
07/06/2017 |
|
| IP/C/M/87, IP/C/M/87/Add.1 |
11 TECHNICAL COOPERATION AND CAPACITY BUILDING |
World Health Organization (WHO) |
19/10/2017-20/10/2017 |
07/02/2018 |
|
| IP/C/M/93, IP/C/M/93/Add.1 |
11 TECHNICAL COOPERATION AND CAPACITY-BUILDING |
World Health Organization (WHO) |
17/10/2019-18/10/2019 |
18/11/2019 |
|
| IP/C/M/93, IP/C/M/93/Add.1 |
14 INTELLECTUAL PROPERTY AND THE PUBLIC INTEREST: R&D COSTS AND PRICING OF MEDICINES AND HEALTH TECHNOLOGIES |
World Health Organization (WHO) |
17/10/2019-18/10/2019 |
18/11/2019 |
|
| IP/C/M/95, IP/C/M/95/Add.1 |
11 TECHNICAL COOPERATION AND CAPACITY BUILDING |
World Health Organization (WHO) |
30/07/2020 |
05/08/2020 |
|
| IP/C/M/95, IP/C/M/95/Add.1 |
14 INTELLECTUAL PROPERTY AND PUBLIC INTEREST: BEYOND ACCESS TO MEDICINES AND MEDICAL TECHNOLOGIES TOWARDS A MORE HOLISTIC APPROACH TO TRIPS FLEXIBILITIES |
World Health Organization (WHO) |
30/07/2020 |
05/08/2020 |
|
| IP/C/M/96, IP/C/M/96/Add.1 |
12 TECHNICAL COOPERATION AND CAPACITY-BUILDING |
World Health Organization (WHO) |
15/10/2020-16/10/2020 |
14/12/2020 |
|
| IP/C/M/96, IP/C/M/96/Add.1 |
12 TECHNICAL COOPERATION AND CAPACITY-BUILDING |
World Health Organization (WHO) |
15/10/2020-16/10/2020 |
14/12/2020 |
|
| IP/C/M/96, IP/C/M/96/Add.1 |
12 TECHNICAL COOPERATION AND CAPACITY-BUILDING |
World Health Organization (WHO) |
15/10/2020-16/10/2020 |
14/12/2020 |
|
| IP/C/M/96, IP/C/M/96/Add.1 |
14 DULY MOTIVATED REQUEST BY LDCS TO EXTEND THE TRANSITION PERIOD UNDER ARTICLE 66.1 OF THE TRIPS AGREEMENT FOR LEAST DEVELOPED COUNTRY MEMBERS |
World Health Organization (WHO) |
15/10/2020-16/10/2020 |
14/12/2020 |
|
| IP/C/M/96, IP/C/M/96/Add.1 |
15 PROPOSAL FOR A WAIVER FROM CERTAIN PROVISIONS OF THE TRIPS AGREEMENT FOR THE PREVENTION, CONTAINMENT AND TREATMENT OF COVID-19 |
World Health Organization (WHO) |
15/10/2020-16/10/2020 |
14/12/2020 |
|
| IP/C/M/98, IP/C/M/98/Add.1 |
12 PROPOSAL FOR A WAIVER FROM CERTAIN PROVISIONS OF THE TRIPS AGREEMENT FOR THE PREVENTION, CONTAINMENT AND TREATMENT OF COVID-19 |
World Health Organization (WHO) |
10/03/2021-11/03/2021 |
08/04/2021 |
|
| IP/C/M/103, IP/C/M/103/Add.1, IP/C/M/Rev.1 |
12 TECHNICAL COOPERATION AND CAPACITY BUILDING |
World Health Organization (WHO) |
13/10/2021-16/12/2021 |
20/02/2022 |
|
| IP/C/M/106, IP/C/M/106/Add.1 |
12 TECHNICAL COOPERATION AND CAPACITY-BUILDING |
World Health Organization (WHO) |
12/10/2022-16/12/2022 |
17/02/2023 |
|
